-
1
-
-
0021780949
-
Plasminogen activators, tissue degradation, and cancer
-
Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985, 44:139-266
-
(1985)
Adv Cancer Res
, vol.44
, pp. 139-266
-
-
Dano, K.1
Andreasen, P.A.2
Grondahl-Hansen, J.3
Kristensen, P.4
Nielsen, L.S.5
Skriver, L.6
-
2
-
-
0027535914
-
Biology and biochemistry of proteinases in tumor invasion
-
Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993, 73:161-195
-
(1993)
Physiol Rev
, vol.73
, pp. 161-195
-
-
Mignatti, P.1
Rifkin, D.B.2
-
3
-
-
0033981473
-
The plasminogen activation system in tumor growth, invasion, and metastasis
-
Andreasen PA, Egelund R, Petersen HH: The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000, 57:25-40
-
(2000)
Cell Mol Life Sci
, vol.57
, pp. 25-40
-
-
Andreasen, P.A.1
Egelund, R.2
Petersen, H.H.3
-
4
-
-
0030788411
-
The urokinase-type plasminogen activator system in cancer metastasis: A review
-
Andreasen PA, Kjoller L, Christensen L, Duffy MJ: The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997, 72:1-22
-
(1997)
Int J Cancer
, vol.72
, pp. 1-22
-
-
Andreasen, P.A.1
Kjoller, L.2
Christensen, L.3
Duffy, M.J.4
-
5
-
-
0030584083
-
Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency
-
Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL: Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 1996, 87:709-719
-
(1996)
Cell
, vol.87
, pp. 709-719
-
-
Bugge, T.H.1
Kombrinck, K.W.2
Flick, M.J.3
Daugherty, C.C.4
Danton, M.J.5
Degen, J.L.6
-
6
-
-
0031470554
-
Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin
-
Chen ZL, Strickland S: Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 1997, 91:917-925
-
(1997)
Cell
, vol.91
, pp. 917-925
-
-
Chen, Z.L.1
Strickland, S.2
-
8
-
-
0025055183
-
Plasminogen activator inhibitors: Hormonally regulated serpins
-
Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN: Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 1990, 68:1-19
-
(1990)
Mol Cell Endocrinol
, vol.68
, pp. 1-19
-
-
Andreasen, P.A.1
Georg, B.2
Lund, L.R.3
Riccio, A.4
Stacey, S.N.5
-
9
-
-
0036005954
-
The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor-1: Roles of the reactive centre loop, the shutter region, the flexible joint region, and the small serpin fragment
-
Wind T, Hansen M, Jensen JK, Andreasen P: The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor-1: roles of the reactive centre loop, the shutter region, the flexible joint region, and the small serpin fragment. Biol Chem 2002, 383:21-36
-
(2002)
Biol Chem
, vol.383
, pp. 21-36
-
-
Wind, T.1
Hansen, M.2
Jensen, J.K.3
Andreasen, P.4
-
10
-
-
0025013834
-
Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer
-
Duffy MJ, Reilly D, O'Sullivan C, O'Higgins N, Fennelly JJ, Andreasen P: Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res 1990, 50:6827-6829
-
(1990)
Cancer Res
, vol.50
, pp. 6827-6829
-
-
Duffy, M.J.1
Reilly, D.2
O'Sullivan, C.3
O'Higgins, N.4
Fennelly, J.J.5
Andreasen, P.6
-
11
-
-
0025995880
-
Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer
-
Janicke F, Schmitt M, Graeff H: Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer. Semin Thromb Hemost 1991, 17:303-312
-
(1991)
Semin Thromb Hemost
, vol.17
, pp. 303-312
-
-
Janicke, F.1
Schmitt, M.2
Graeff, H.3
-
12
-
-
7344248988
-
Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice
-
Bugge TH, Lund LR, Kombrinck KK, Nielsen BS, Holmback K, Drew AF, Flick MJ, Witte DP, Dano K, Degen JL: Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene 1998, 16:3097-3104
-
(1998)
Oncogene
, vol.16
, pp. 3097-3104
-
-
Bugge, T.H.1
Lund, L.R.2
Kombrinck, K.K.3
Nielsen, B.S.4
Holmback, K.5
Drew, A.F.6
Flick, M.J.7
Witte, D.P.8
Dano, K.9
Degen, J.L.10
-
13
-
-
0027223048
-
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
-
Grondahl-Hansen J, Christensen IJ, Rosenquist C, Brunner N, Mouridsen HT, Dano K, Blichert-Toft M: High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 1993, 53:2513-2521
-
(1993)
Cancer Res
, vol.53
, pp. 2513-2521
-
-
Grondahl-Hansen, J.1
Christensen, I.J.2
Rosenquist, C.3
Brunner, N.4
Mouridsen, H.T.5
Dano, K.6
Blichert-Toft, M.7
-
14
-
-
0030857717
-
Clinical impact of the plasminogen activation system in tumor invasion and metastasis: Prognostic relevance and target for therapy
-
Schmitt, M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Hofler H, Janicke F, Graeff H: Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 1997, 78:285-296
-
(1997)
Thromb Haemost
, vol.78
, pp. 285-296
-
-
Schmitt, M.1
Harbeck, N.2
Thomssen, C.3
Wilhelm, O.4
Magdolen, V.5
Reuning, U.6
Ulm, K.7
Hofler, H.8
Janicke, F.9
Graeff, H.10
-
15
-
-
0036329424
-
Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: From pilot to level 1 evidence studies
-
Duffy MJ: Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies. Clin Chem 2002, 48:1194-1197
-
(2002)
Clin Chem
, vol.48
, pp. 1194-1197
-
-
Duffy, M.J.1
-
16
-
-
0037445194
-
Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer
-
Zemzoum I, Kates RE, Ross JS, Dettmar P, Dutta M, Henrichs C, Yurdseven S, Hofler H, Kiechle M, Schmitt M, Harbeck N: Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer. J Clin Oncol 2003, 21:1022-1028
-
(2003)
J Clin Oncol
, vol.21
, pp. 1022-1028
-
-
Zemzoum, I.1
Kates, R.E.2
Ross, J.S.3
Dettmar, P.4
Dutta, M.5
Henrichs, C.6
Yurdseven, S.7
Hofler, H.8
Kiechle, M.9
Schmitt, M.10
Harbeck, N.11
-
17
-
-
0036695216
-
Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts
-
Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Janicke F, Thomssen C: Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts. Clin Breast Cancer 2002, 3:196-200
-
(2002)
Clin Breast Cancer
, vol.3
, pp. 196-200
-
-
Harbeck, N.1
Schmitt, M.2
Kates, R.E.3
Kiechle, M.4
Zemzoum, I.5
Janicke, F.6
Thomssen, C.7
-
18
-
-
0030815119
-
Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model
-
Ma D, Gerard RD, Li XY, Alizadeh H, Niederkorn JY: Inhibition of metastasis of intraocular melanomas by adenovirus-mediated gene transfer of plasminogen activator inhibitor type 1 (PAI-1) in an athymic mouse model Blood 1997, 90:2738-2746
-
(1997)
Blood
, vol.90
, pp. 2738-2746
-
-
Ma, D.1
Gerard, R.D.2
Li, X.Y.3
Alizadeh, H.4
Niederkorn, J.Y.5
-
19
-
-
0028821827
-
Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model
-
Soff GA, Sanderowitz J, Gately S, Verrusio E, Weiss I, Brem S, Kwaan HC: Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model. J Clin Invest 1995, 96:2593-2600
-
(1995)
J Clin Invest
, vol.96
, pp. 2593-2600
-
-
Soff, G.A.1
Sanderowitz, J.2
Gately, S.3
Verrusio, E.4
Weiss, I.5
Brem, S.6
Kwaan, H.C.7
-
20
-
-
0037146737
-
Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis
-
Praus M, Collen D, Gerard RD: Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis. Int J Cancer 2002, 102:584-591
-
(2002)
Int J Cancer
, vol.102
, pp. 584-591
-
-
Praus, M.1
Collen, D.2
Gerard, R.D.3
-
21
-
-
0031056819
-
Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice
-
Jankun J, Keck RW, Skrzypczak-Jankun E, Swiercz R: Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice [published erratum appears in Cancer Res 1998 Jan 1;58(1):179]. Cancer Res 1997, 57:559-563
-
(1997)
Cancer Res
, vol.57
, pp. 559-563
-
-
Jankun, J.1
Keck, R.W.2
Skrzypczak-Jankun, E.3
Swiercz, R.4
-
22
-
-
0031974509
-
-
published erratum appears Jan 1
-
Jankun J, Keck RW, Skrzypczak-Jankun E, Swiercz R: Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice [published erratum appears in Cancer Res 1998 Jan 1;58(1):179]. Cancer Res 1997, 57:559-563
-
(1998)
Cancer Res
, vol.58
, Issue.1
, pp. 179
-
-
-
23
-
-
0035823504
-
Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis
-
McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA: Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 2001, 276:33964-33968
-
(2001)
J Biol Chem
, vol.276
, pp. 33964-33968
-
-
McMahon, G.A.1
Petitclerc, E.2
Stefansson, S.3
Smith, E.4
Wong, M.K.5
Westrick, R.J.6
Ginsburg, D.7
Brooks, P.C.8
Lawrence, D.A.9
-
24
-
-
0029956043
-
Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma
-
Eitzman DT, Krauss JC, Shen T, Cui J, Ginsburg: Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma. Blood 1996, 87:4718-4722
-
(1996)
Blood
, vol.87
, pp. 4718-4722
-
-
Eitzman, D.T.1
Krauss, J.C.2
Shen, T.3
Cui, J.4
Ginsburg5
-
25
-
-
0031902286
-
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
-
Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM: Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 1998, 4:923-928
-
(1998)
Nat Med
, vol.4
, pp. 923-928
-
-
Bajou, K.1
Noel, A.2
Gerard, R.D.3
Masson, V.4
Brunner, N.5
Holst-Hansen, C.6
Skobe, M.7
Fusenig, N.E.8
Carmeliet, P.9
Collen, D.10
Foidart, J.M.11
-
26
-
-
0035911151
-
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies
-
Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM, Noel A: The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 2001, 152:777-784
-
(2001)
J Cell Biol
, vol.152
, pp. 777-784
-
-
Bajou, K.1
Masson, V.2
Gerard, R.D.3
Schmitt, P.M.4
Albert, V.5
Praus, M.6
Lund, L.R.7
Frandsen, T.L.8
Brunner, N.9
Dano, K.10
Fusenig, N.E.11
Weidle, U.12
Carmeliet, G.13
Loskutoff, D.14
Collen, D.15
Carmeliet, P.16
Foidart, J.M.17
Noel, A.18
-
27
-
-
0042804870
-
Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene deficient mice
-
Almholt K, Nielsen BS, Frandsen TL, Brunner N, Dano K, Johnsen M: Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene deficient mice. Oncogene 2003, 22:4389-4397
-
(2003)
Oncogene
, vol.22
, pp. 4389-4397
-
-
Almholt, K.1
Nielsen, B.S.2
Frandsen, T.L.3
Brunner, N.4
Dano, K.5
Johnsen, M.6
-
28
-
-
17744377410
-
Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization
-
Lambert V, Munaut C, Noel A, Frankenne F, Bajou K, Gerard R, Carmeliet P, Defresne MP, Foidart JM, Rakic JM: Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. EMBO J 2001, 15:1021-1027
-
(2001)
EMBO J
, vol.15
, pp. 1021-1027
-
-
Lambert, V.1
Munaut, C.2
Noel, A.3
Frankenne, F.4
Bajou, K.5
Gerard, R.6
Carmeliet, P.7
Defresne, M.P.8
Foidart, J.M.9
Rakic, J.M.10
-
29
-
-
18244389007
-
The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
-
Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, Noel A, Foidart JM: The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. EMBO J 2002, 16:147-154
-
(2002)
EMBO J
, vol.16
, pp. 147-154
-
-
Devy, L.1
Blacher, S.2
Grignet-Debrus, C.3
Bajou, K.4
Masson, V.5
Gerard, R.D.6
Gils, A.7
Carmeliet, G.8
Carmeliet, P.9
Declerck, P.J.10
Noel, A.11
Foidart, J.M.12
-
30
-
-
0025785994
-
Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: Possible roles in tumor progression and metastasis
-
Sumiyoshi K, Baba S, Sakaguchi S, Urano T, Takada Y, Takada A: Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb Res 1991, 63:59-71
-
(1991)
Thromb Res
, vol.63
, pp. 59-71
-
-
Sumiyoshi, K.1
Baba, S.2
Sakaguchi, S.3
Urano, T.4
Takada, Y.5
Takada, A.6
-
31
-
-
0027361935
-
Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers
-
Jankun J, Merrick HW, Goldblatt PJ: Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers. J Cell Biochem 1993, 53:135-144
-
(1993)
J Cell Biochem
, vol.53
, pp. 135-144
-
-
Jankun, J.1
Merrick, H.W.2
Goldblatt, P.J.3
-
32
-
-
0028959504
-
Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer
-
Bianchi E, Cohen RL, Dai A, Thor AT, Shuman MA, Smith HS: Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer 1995, 60:597-603
-
(1995)
Int J Cancer
, vol.60
, pp. 597-603
-
-
Bianchi, E.1
Cohen, R.L.2
Dai, A.3
Thor, A.T.4
Shuman, M.A.5
Smith, H.S.6
-
33
-
-
0029992385
-
Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas
-
Christensen L, Wiborg Simonsen AC, Heegaard CW, Moestrup SK, Andersen JA, Andreasen PA: Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas. Int J Cancer 1996, 66:441-452
-
(1996)
Int J Cancer
, vol.66
, pp. 441-452
-
-
Christensen, L.1
Wiborg Simonsen, A.C.2
Heegaard, C.W.3
Moestrup, S.K.4
Andersen, J.A.5
Andreasen, P.A.6
-
34
-
-
0029968743
-
Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues
-
Costantini V, Sidoni A, Deveglia R, Cazzato OA, Bellezza G, Ferri I, Bucciarelli E, Nenci GG: Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues. Cancer 1996, 77:1079-1088
-
(1996)
Cancer
, vol.77
, pp. 1079-1088
-
-
Costantini, V.1
Sidoni, A.2
Deveglia, R.3
Cazzato, O.A.4
Bellezza, G.5
Ferri, I.6
Bucciarelli, E.7
Nenci, G.G.8
-
35
-
-
0030703165
-
Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues
-
Umeda T, Eguchi Y, Okino K, Kodama M, Hattori T: Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues. J Pathol 1997, 183:88-397
-
(1997)
J Pathol
, vol.183
, pp. 88-397
-
-
Umeda, T.1
Eguchi, Y.2
Okino, K.3
Kodama, M.4
Hattori, T.5
-
36
-
-
0033050260
-
Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue
-
Ferrier CM, de Witte HH, Straatman H, van Tienoven DH, van Geloof WL, Rietveld FJ, Sweep CG, Ruiter DJ, van Mujien GN: Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue. Br J Cancer 1999, 79:1534-1541
-
(1999)
Br J Cancer
, vol.79
, pp. 1534-1541
-
-
Ferrier, C.M.1
De Witte, H.H.2
Straatman, H.3
Van Tienoven, D.H.4
Van Geloof, W.L.5
Rietveld, F.J.6
Sweep, C.G.7
Ruiter, D.J.8
Van Mujien, G.N.9
-
37
-
-
0033820073
-
Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma: Fibroblastic expression has strong associations with tumor pathology
-
Dublin E, Hanby A, Patel NK, Liebman R, Barnes D: Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma: fibroblastic expression has strong associations with tumor pathology. Am J Pathol 2000, 157:1219-1227
-
(2000)
Am J Pathol
, vol.157
, pp. 1219-1227
-
-
Dublin, E.1
Hanby, A.2
Patel, N.K.3
Liebman, R.4
Barnes, D.5
-
38
-
-
0036360538
-
Immunohistochemical expression of uPA, PAI-1, cathepsin D and apoptotic cells in ductal carcinoma in situ of the breast
-
Zhao H, Morimoto T, Sasa M, Tanaka T, Izumi K: Immunohistochemical expression of uPA, PAI-1, cathepsin D and apoptotic cells in ductal carcinoma in situ of the breast. Breast Cancer 2002, 9:118-126
-
(2002)
Breast Cancer
, vol.9
, pp. 118-126
-
-
Zhao, H.1
Morimoto, T.2
Sasa, M.3
Tanaka, T.4
Izumi, K.5
-
39
-
-
0031962017
-
Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor
-
Rodenburg KW, Kjoller L, Petersen HH, Andreasen PA: Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor. Biochem J 1998, 329:55-63
-
(1998)
Biochem J
, vol.329
, pp. 55-63
-
-
Rodenburg, K.W.1
Kjoller, L.2
Petersen, H.H.3
Andreasen, P.A.4
-
40
-
-
0037134909
-
The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand
-
Jensen JK, Wind T, Andreasen PA: The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand. FEBS Lett 2002, 521:91-94
-
(2002)
FEBS Lett
, vol.521
, pp. 91-94
-
-
Jensen, J.K.1
Wind, T.2
Andreasen, P.A.3
-
41
-
-
0026333459
-
Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies
-
Munch M, Heegaard C, Jensen PH, Andreasen PA: Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies. FEBS Lett 1991, 295:102-106
-
(1991)
FEBS Lett
, vol.295
, pp. 102-106
-
-
Munch, M.1
Heegaard, C.2
Jensen, P.H.3
Andreasen, P.A.4
-
42
-
-
0020352040
-
Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody
-
Nielsen LS, Hansen JG, Skriver L, Wilson EL, Kaltoft K, Zeuthen J, Dano K: Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry 1982, 21:6410-6415
-
(1982)
Biochemistry
, vol.21
, pp. 6410-6415
-
-
Nielsen, L.S.1
Hansen, J.G.2
Skriver, L.3
Wilson, E.L.4
Kaltoft, K.5
Zeuthen, J.6
Dano, K.7
-
43
-
-
0031897322
-
Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques
-
Ferrier CM, van Geloof WL, de Witte HH, Kramer MD, Ruiter DJ, van Muijen GN: Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques. J Histochem Cytochem 1998, 46:469-476
-
(1998)
J Histochem Cytochem
, vol.46
, pp. 469-476
-
-
Ferrier, C.M.1
Van Geloof, W.L.2
De Witte, H.H.3
Kramer, M.D.4
Ruiter, D.J.5
Van Muijen, G.N.6
-
44
-
-
0033665746
-
Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies
-
Floridon C, Nielsen O, Holund B, Sweep F, Sunde L, Thomsen SG, Teisner B: Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Placenta 2000, 21:754-762
-
(2000)
Placenta
, vol.21
, pp. 754-762
-
-
Floridon, C.1
Nielsen, O.2
Holund, B.3
Sweep, F.4
Sunde, L.5
Thomsen, S.G.6
Teisner, B.7
-
45
-
-
0018182699
-
A better cell line for making hybridomas secreting specific antibodies
-
Shulman M, Wilde CD, Kohler G: A better cell line for making hybridomas secreting specific antibodies. Nature 1978, 276:269-270
-
(1978)
Nature
, vol.276
, pp. 269-270
-
-
Shulman, M.1
Wilde, C.D.2
Kohler, G.3
-
46
-
-
0026377425
-
The plasminogen activation system in human colon cancer: Messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma
-
Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Dano K: The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res 1991, 51:4067-4071
-
(1991)
Cancer Res
, vol.51
, pp. 4067-4071
-
-
Pyke, C.1
Kristensen, P.2
Ralfkiaer, E.3
Eriksen, J.4
Dano, K.5
-
47
-
-
0035476863
-
Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas
-
Nielsen BS, Rank F, Lopez JM, Balbin M, Vizoso F, Lund LR, Dano K, Lopez-Otin C: Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 2001, 61:7091-7100
-
(2001)
Cancer Res
, vol.61
, pp. 7091-7100
-
-
Nielsen, B.S.1
Rank, F.2
Lopez, J.M.3
Balbin, M.4
Vizoso, F.5
Lund, L.R.6
Dano, K.7
Lopez-Otin, C.8
-
48
-
-
0022881517
-
A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation
-
Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G: A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986, 103:2787-2796
-
(1986)
J Cell Biol
, vol.103
, pp. 2787-2796
-
-
Skalli, O.1
Ropraz, P.2
Trzeciak, A.3
Benzonana, G.4
Gillessen, D.5
Gabbiani, G.6
-
49
-
-
0023939143
-
Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues
-
Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G: Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 1988, 41:707-712
-
(1988)
Int J Cancer
, vol.41
, pp. 707-712
-
-
Sappino, A.P.1
Skalli, O.2
Jackson, B.3
Schurch, W.4
Gabbiani, G.5
-
50
-
-
0027725137
-
PG-MI: A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule
-
Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A: PG-MI: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993, 142:1359-1372
-
(1993)
Am J Pathol
, vol.142
, pp. 1359-1372
-
-
Falini, B.1
Flenghi, L.2
Pileri, S.3
Gambacorta, M.4
Bigerna, B.5
Durkop, H.6
Eitelbach, F.7
Thiele, J.8
Pacini, R.9
Cavaliere, A.10
-
51
-
-
0023706144
-
Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer
-
Guelstein VI, Tchypysheva TA, Ermilova VD, Litvinova LV, Troyanovsky SM, Bannikov GA: Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. Int J Cancer 1988, 42:147-153
-
(1988)
Int J Cancer
, vol.42
, pp. 147-153
-
-
Guelstein, V.I.1
Tchypysheva, T.A.2
Ermilova, V.D.3
Litvinova, L.V.4
Troyanovsky, S.M.5
Bannikov, G.A.6
-
52
-
-
0035165524
-
Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer
-
Nielsen BS, Sehested M, Duun S, Rank F, Timshel S, Rygaard J, Johnsen M, Dano K: Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer. Lab Invest 2001, 81:1485-1501
-
(2001)
Lab Invest
, vol.81
, pp. 1485-1501
-
-
Nielsen, B.S.1
Sehested, M.2
Duun, S.3
Rank, F.4
Timshel, S.5
Rygaard, J.6
Johnsen, M.7
Dano, K.8
-
53
-
-
0037434421
-
Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients
-
Hansen S, Overgaard J, Rose C, Knoop A, Laenkholm AV, Andersen J, Sorensen FB, Andreasen PA: Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients. Br J Cancer 2003, 88:102-108
-
(2003)
Br J Cancer
, vol.88
, pp. 102-108
-
-
Hansen, S.1
Overgaard, J.2
Rose, C.3
Knoop, A.4
Laenkholm, A.V.5
Andersen, J.6
Sorensen, F.B.7
Andreasen, P.A.8
-
54
-
-
0028890174
-
The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells
-
Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ: The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995, 95:859-873
-
(1995)
J Clin Invest
, vol.95
, pp. 859-873
-
-
Ronnov-Jessen, L.1
Petersen, O.W.2
Koteliansky, V.E.3
Bissell, M.J.4
-
55
-
-
0030061754
-
Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer
-
Nielsen BS, Sehested M, Timshel S, Pyke C, Dano K: Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Lab Invest 1996, 74:168-177
-
(1996)
Lab Invest
, vol.74
, pp. 168-177
-
-
Nielsen, B.S.1
Sehested, M.2
Timshel, S.3
Pyke, C.4
Dano, K.5
-
56
-
-
0035863308
-
Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model
-
Frandsen TL, Holst-Hansen C, Nielsen BS, Christensen IJ, Nyengaard JR, Carmeliet P, Brunner N: Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Cancer Res 2001, 61:532-537
-
(2001)
Cancer Res
, vol.61
, pp. 532-537
-
-
Frandsen, T.L.1
Holst-Hansen, C.2
Nielsen, B.S.3
Christensen, I.J.4
Nyengaard, J.R.5
Carmeliet, P.6
Brunner, N.7
-
57
-
-
0036005960
-
Role of myofibroblasts at the invasion front
-
De Wever O, Mareel M: Role of myofibroblasts at the invasion front. Biol Chem 2002, 383:55-67
-
(2002)
Biol Chem
, vol.383
, pp. 55-67
-
-
De Wever, O.1
Mareel, M.2
-
58
-
-
0036512208
-
New functions for the matrix metalloproteinases in cancer progression
-
Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 161-174
-
-
Egeblad, M.1
Werb, Z.2
-
59
-
-
0030051051
-
Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction
-
Ronnov-Jessen L, Petersen OW, Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996, 76:69-125
-
(1996)
Physiol Rev
, vol.76
, pp. 69-125
-
-
Ronnov-Jessen, L.1
Petersen, O.W.2
Bissell, M.J.3
-
60
-
-
0030665289
-
The human myoepithelial cell is a natural tumor suppressor
-
Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH: The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 1997, 3:1949-1958
-
(1997)
Clin Cancer Res
, vol.3
, pp. 1949-1958
-
-
Sternlicht, M.D.1
Kedeshian, P.2
Shao, Z.M.3
Safarians, S.4
Barsky, S.H.5
-
61
-
-
0034665101
-
Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma
-
Cho SH, Tam SW, Demissie-Sanders S, Filler SA, Oh CK: Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol 2000, 165:3154-3161
-
(2000)
J Immunol
, vol.165
, pp. 3154-3161
-
-
Cho, S.H.1
Tam, S.W.2
Demissie-Sanders, S.3
Filler, S.A.4
Oh, C.K.5
-
62
-
-
0037100538
-
C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils
-
Wojta J, Kaun C, Zorn G, Ghannadan M, Hauswirth AW, Sperr WR, Fritsch G, Printz D, Binder BR, Schatzl G, Zwirner J, Maurer G, Huber K, Valent P: C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils Blood 2002, 100:517-523
-
(2002)
Blood
, vol.100
, pp. 517-523
-
-
Wojta, J.1
Kaun, C.2
Zorn, G.3
Ghannadan, M.4
Hauswirth, A.W.5
Sperr, W.R.6
Fritsch, G.7
Printz, D.8
Binder, B.R.9
Schatzl, G.10
Zwirner, J.11
Maurer, G.12
Huber, K.13
Valent, P.14
|